Today: 21 May 2026
Browse Category

NYSE:UNF 19 December 2025 - 6 March 2026

UniFirst Corporation Stock Jumps After Report Says Cintas Is Nearing a Deal Above $275 a Share

UniFirst Corporation Stock Jumps After Report Says Cintas Is Nearing a Deal Above $275 a Share

Cintas is in advanced talks to acquire UniFirst for over $275 a share, or about $5.2 billion, Bloomberg Law reported. UniFirst stock jumped 13.6% in premarket trading Friday. The companies have negotiated on and off since 2022, with Cintas’ latest offer representing a 64% premium. Any deal would require a contract, shareholder approval, and could face antitrust scrutiny.
6 March 2026
··
UniFirst stock jumps after report of renewed Cintas takeover talks — what investors watch next

UniFirst stock jumps after report of renewed Cintas takeover talks — what investors watch next

UniFirst shares surged 15% to $230.01 premarket Tuesday after Bloomberg reported takeover talks with Cintas. Cintas confirmed a $275-per-share cash offer in December, valuing UniFirst at $5.2 billion. UniFirst’s board is reviewing the proposal with advisers and has not commented further. Trading volume in UniFirst quadrupled, while investors await updates from either company.
11 February 2026
··
UniFirst Corporation Stock (UNF) Jumps After Cintas Renews $275 Buyout Offer — News, Forecasts, and What’s Next

UniFirst Corporation Stock (UNF) Jumps After Cintas Renews $275 Buyout Offer — News, Forecasts, and What’s Next

Cintas Corporation made a $5.2 billion all-cash offer to acquire UniFirst at $275 per share, its third attempt to buy the company. UniFirst confirmed receipt of the non-binding proposal and said its board is reviewing the bid. UniFirst shares jumped 18% to $201 after the news, well below the offer price. Cintas included a $350 million reverse termination fee if regulators block the deal.
22 December 2025
···
UniFirst Corporation Stock (NYSE: UNF) Drops on Dec. 19, 2025 as Proxy Fight Aftershocks Collide With Mixed Wall Street Forecasts

UniFirst Corporation Stock (NYSE: UNF) Drops on Dec. 19, 2025 as Proxy Fight Aftershocks Collide With Mixed Wall Street Forecasts

UniFirst shares fell about 3% to $168.60 intraday on Dec. 19, 2025, after board election results showed company nominees Nowicki and Sintros won seats with support from Class B shares, despite activist nominees leading among common shareholders. Nowicki was named board chairman. Engine Capital, the activist investor, claimed a mandate for change based on the common stock vote.
19 December 2025
·

Stock Market Today

  • 3 Middle Eastern Penny Stocks With Market Caps Over US$3M
    May 21, 2026, 12:54 AM EDT. Investors cautious amid geopolitical risks and volatile oil. Three Middle Eastern penny stocks spotlighted for strong financials despite challenges. Airtouch Solar Ltd (market cap ₪15.08M) cut losses 11% annually, with revenue of ₪38.03M but increased net loss of ₪8.12M, maintaining more cash than debt and a 3-year cash runway. Big Tech 50 R&D (market cap ₪10.75M) is pre-revenue, reducing net loss to $2.85M, debt-free with 3+ years cash runway, led by an experienced board. Sonovia Ltd (market cap ₪9.27M) develops anti-bacterial textiles, details limited in the report. These firms show potential in under-the-radar Middle Eastern markets amid uncertain environment.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop